TRAW
Financials
- Market Capitalization 10.61 M
- Employee 7
- Founded 1998
- CEO N/A
- Website www.trawspharma.com
- Headquarter Delaware, United States
- FIGI BBG000R338X6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4794 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.48 USD | +0.81% | -2.36% | +1.22% | +18.10% | 10.99 M USD | ||
| 4796 |  XCUR Exicure, Inc. - Common Stock | 1.72 USD | +4.24% | -15.69% | -38.13% | -73.90% | 10.96 M USD | ||
| 4808 |  VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.25 USD | 0.00% | +8.70% | -56.90% | -51.47% | 10.26 M USD | ||
| 4809 |  MTVA MetaVia Inc. - Common Stock | 1.93 USD | -3.02% | +22.15% | +11.56% | +183.82% | 9.97 M USD |
Frequently asked questions about Traws Pharma, Inc. - Common Stock
What is the Traws Pharma, Inc. - Common Stock stock price today?
The current price of Traws Pharma, Inc. - Common Stock (TRAW) is 0.7. Over the past 24 hours, the stock has changed by +2.94%. Follow the TRAW chart for real-time price dynamics.
What is the stock ticker of Traws Pharma, Inc. - Common Stock?
Traws Pharma, Inc. - Common Stock trades under the ticker TRAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Traws Pharma, Inc. - Common Stock stock going up?
TRAW has changed by +1.45% over the last week, -7.89% over the last month, and -53.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Traws Pharma, Inc. - Common Stock net income for the last quarter?
Traws Pharma, Inc. - Common Stock reported net income of -7.11 M for the last quarter. The previous quarter showed -3.96 M, which means net income changed by -79.38%.
How many employees does Traws Pharma, Inc. - Common Stock have?
As of the latest available data, Traws Pharma, Inc. - Common Stock has 7 employees. Workforce size can provide additional context about the company's scale and operations.
What is Traws Pharma, Inc. - Common Stock EBITDA?
Traws Pharma, Inc. - Common Stock EBITDA is -6.84 M, and its EBITDA margin is -12.01 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Traws Pharma, Inc. - Common Stock stock?
You can buy Traws Pharma, Inc. - Common Stock (TRAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Traws Pharma, Inc. - Common Stock stock?
Investing in Traws Pharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TRAW chart and related analysis on metatrader.com as part of your research.